To access all features of this site, you must enable Javascript. Here are the instructions for enabling Javascript in your web browser.
The François Jacob Institute of Biology brings together five departments and three services
The last two years in scientific news
In June 2022, six young researchers were recognized for their major scientific contributions to biology at the French Academy of Sciences' "Great French Advances in Biology" event. Among them was Paul Frémont, PhD student at Genoscope (CEA-Jacob) and LSCE.
Genopole held its first D4GEN Hackathon on 19–21 May 2022 with the goal of creating interdisciplinary, computational genomics communities aimed particularly at the sharing, preservation and (re)use of genomics Big Data. Jérôme Arnoux, PhD student at LABGeM (Genoscope), led the team that took home the third-place prize from that competition.
Researchers from IDMIT describe the course of immune & inflammatory markers and the vaginal microbiome during the menstrual cycle.
With massively parallel sequencing of DNA collected from the surfaces of the earth's oceans and seas (Tara Oceans expeditions) and more than ten years of analysis, an international team piloted by researchers from Genoscope (CEA-Jacob) and the CNRS has solved one of environmental biology's greatest puzzles.
A team of researchers from IRCM (CEA-Jacob) and I2BC have shed light on the role of ComFC, a bacterial protein involved in natural transformation, itself a driving mechanism for the propagation of antibiotic resistance genes and virulence factors.
In an article published in Cell Reports, an international team including researchers from MIRCen showed that a cerebral network associated with highly elaborate cognitive capacities in humans differs from the comparable network in non-human primates.
A preclinical multimodal imaging study conducted by the Neurodegenerative Diseases Laboratory (LMN/MIRCen) and published in Human Molecular Genetics has shed light on cerebral alterations in Huntington's disease.
Following the Rare Disease Research Challenge Call launched by the European Joint Programme for Rare Disease and the Rare Disease Foundation, the European INDENEO consortium project has been selected to respond to the challenge targeting the development of a system for intranasal administration of biological drugs to newborns. Among the partners of this project, IDMIT brings its expertise in preclinical trials.
CEA-Jacob is collaborating with Ÿnsect in an industrial program, ŸNFABRE, devoted to the genetics of the Tenebrio Molitor beetle larva. This program has been awarded funding under the "Structuring Projects for Competitiveness" program of the French government's investment program for the future (PIA), operated by Bpifrance. It is in line with the actions carried out by Ÿnsect and the CEA, recently supported by Horizon H2020 and the ANR.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.